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Neural crest cells form diverse derivatives that vary according to their level of origin along the body axis,
with only cranial neural crest cells contributing to facial skeleton. Interestingly, the transcription factor
Ets-1 is uniquely expressed in cranial but not trunk neural crest, where it functions as a direct input into
neural crest speciﬁer genes, Sox10 and FoxD3. We have isolated and interrogated a cis-regulatory
element, conserved between birds and mammals, that drives reporter expression in a manner that
recapitulates that of endogenous Ets-1 expression in the neural crest. Within a minimal Ets-1 enhancer
region, mutation of putative binding sites for SoxE, homeobox, Ets, TFAP2 or Fox proteins results in loss
or reduction of neural crest enhancer activity. Morpholino-mediated loss-of-function experiments show
that Sox9, Pax7, Msx1/2, Ets-1, TFAP2A and FoxD3, all are required for enhancer activity. In contrast,
mutation of a putative cMyc/E-box sequence augments reporter expression, consistent with this being a
repressor binding site. Taken together, these results uncover new inputs into Ets-1, revealing critical links
in the cranial neural crest gene regulatory network.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The neural crest is an embryonic stem/progenitor cell popula-
tion characterized by its extensive migratory ability and multi-
potency. Neural crest cells arise within the central nervous system,
but subsequently emigrate to give rise to numerous derivatives
that differ accordingly to their axial level of origin. For example,
the cranial neural crest makes all glia and some neurons of the
peripheral nervous system of the head, as well as contributing to
the cornea and craniofacial skeleton. In contrast, the trunk neural
crest does not contribute to cartilage or bone, and cannot do so
even when transplanted to the head, but does contribute to
peripheral nervous system and melanocytes of the skin. Between
cranial and trunk is the vagal neural crest, which forms the enteric
nervous system, and is responsible for septation of the heart and
outﬂow tract.
One possible explanation for the apparent regional differences
in the neural crest's ability to form different derivatives is that the
gene regulatory events underlying neural crest development differ
according to axial level. Indeed there is evidence that the enhan-
cers mediating expression of some key neural crest genes in the
head are different from those that mediate expression in the trunk.
For example, Sox10, a transcription factor critical for formation of
nearly all neural crest lineages, has a different enhancer respon-
sible for cranial than for trunk expression (Betancur et al., 2010b).
Similarly, another neural crest gene, FoxD3, has a cranial-speciﬁc
enhancer that mediates its initial expression in the dorsal neural
tube (Simões-Costa et al., 2012). Interestingly, a common input
into the cranial-speciﬁc enhancers for Sox10 and FoxD3 is the
transcription factor Ets-1 (Betancur et al., 2010b; Simões-Costa
et al., 2012).
Ets-1 is a winged helix-turn-helix transcription factor that is
expressed in the premigratory cranial but not trunk neural crest
(Tahtakran and Selleck, 2003). In fact, Ets-1 is one of the few
transcription factors known to be selectively expressed in a
subpopulation of the neural crest. Indeed, ectopic expression of
Ets-1 at trunk levels causes changes in the character of emigrating
neural crest cells, making them more cranial-like (Théveneau
et al., 2007). In humans and mice, mutations in Ets-1 lead to
craniofacial anomalies and septation defects of the heart (Ye et al.,
2010; Gao et al., 2010).
Given the importance of Ets-1 in regulating key neural crest
speciﬁer genes Sox10 and FoxD3, identifying the upstream factors
that control Ets-1 expression holds the promise of revealing novel
critical inputs and links in the gene regulatory network (GRN)
underlying neural crest formation. To this end, we have isolated a
region adjacent to the Ets-1 coding region that is capable of
driving GFP in a manner that recapitulates endogenous Ets-1
expression in the cranial neural crest. The results show that
Msx1/2, Pax7, Sox9, FoxD3 and TFAP2A, are critical for activation
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of Ets-1 activity in the neural crest. By taking advantage of the
power of cis-regulatory dissection, our ﬁndings help to expand the
cranial neural crest gene regulatory network.
Materials and methods
Isolation of conserved regions
Using the UCSC Gene browser (Kent et al., 2002), we identiﬁed
regions in the chicken genome in the vicinity of the Ets-1 coding
region that are conserved among vertebrates. Using PCR, we
ampliﬁed the conserved regions from the BAC clone CH261-52I7
(ARK Genomics) and cloned them into the vector pTK-GFP which
contains a basal TK promoter driving GFP expression. We cloned
conserved regions upstream and downstream of the coding region
as well as conserved regions within introns. Generally, the size of
the cloned fragments was less than 1 kb, though in some cases, we
ampliﬁed several adjoining Conserved Regions in a larger clone.
Electroporation
The cloned Conserved Regions were electoporated into HH
stage 4 (Hamburger and Hamilton, 1953) embryos ex ovo as
previously described (Sauka-Spengler and Barembaum, 2008).
After 18 h the GFP expression was examined in unﬁxed embryos.
Using this procedure we were able to electroporate the entire
embryo. Once a clone was identiﬁed with the requisite neural crest
expression, potential transcription factor binding sites were iden-
tiﬁed using the Jaspar database (Bryne et al., 2008) and mutated
using fusion PCR (Szewczyk et al., 2006). The plasmid with the
mutated enhancer was co-electroporated with a plasmid contain-
ing the non-mutated enhancer driving Cherry expression.
The enhancer activity of the mutant construct driving GFP was
then compared to the non-mutated construct driving Cherry in the
same embryo, thus controlling for electroporation efﬁciency.
Antisense morpholino oligos (MO) (1.5 mM) (Gene-Tools, Philo-
math, OR) aimed at the putative regulators were co-electroporated
with reporter constructs (1 mg/ml) on the right side (dorsal side
up) and a control morpholino oligo (1.5 mM) and reporter
construct (1 mg/ml) on the contralateral side.
In situ hybridization
Whole mount in situ hybridization was performed according to
the previous protocols (Wilkinson, 1992) using the Chicken EST
clone ChEST218o8 from the BBSRC database (Boardman et al.
2002).
Results
Endogenous pattern of chick Ets-1 expression in the neural crest
Ets-1 transcripts are expressed in the premigratory neural
crest, with onset of expression at the 4 somite stage (4ss;
Fig. 1A). Expression is retained on migrating cranial and vagal
neural crest cells, but is absent from the trunk premigratory or
migrating neural crest (Fig. 1B and C). Later, Ets-1 expression is
maintained as crest cells reach their ﬁnal position in the fronto-
nasal process and branchial arches (Fig. 1D). In addition to the
cranial neural crest, Ets-1 is observed in the caudal half of the otic
vesicle (Fig. 1C) as well as endothelial cells of the body and
extraembryonic regions, which exhibit high levels of Ets-1 expres-
sion at all stages examined (Fig. 1) (Tahtakran and Selleck, 2003).
Identiﬁcation of the Ets-1 regulatory region mediating neural crest
expression
Using the UCSC gene browser, we identiﬁed regions in the
vicinity of the Ets-1 coding region that are conserved between
birds and mammals. Conserved fragments were isolated by PCR
and cloned into an EGFP reporter vector upstream of a thymidine
kinase (TK) basal promoter (Uchikawa et al., 2003). Using an ex ovo
electroporation technique (Sauka-Spengler and Barembaum,
2008), the embryonic ectoderm of HH stage 4 embryos was
electroporated with the reporter construct together with a ubiqui-
tously expressed pCIG H2B-RFP to assess the efﬁciency of transfec-
tion. Embryos were cultured to HH stages 9–14 (Hamburger and
Hamilton, 1953), and analyzed for GFP and RFP expression.
The RFP was expressed throughout the rostrocaudal axis of the
embryos (data not shown). Of the regions tested, which included
regions on either side of the coding region as well as introns, only
one conserved region mediated GFP activity at the stages exam-
ined. This 694 bb region, which we refer to as Ets Conserved
Region (ECR) 1 (Fig. 2A), drove expression of GFP in chicken
embryos (Fig. 2B–E) in a pattern that reﬂects endogenous Ets-1
expression in the cranial neural crest and otic placode. GFP
expression was ﬁrst observed at the 6 somite stage (HH stage 9)
in premigratory crest cells in the dorsal neural tube (Fig. 2B). Later,
GFP was detected in emigrating cranial neural crest departing the
neural tube (HH stage 10, Fig. 2C) and migrating at HH stage 12
(Fig. 2D) toward their ﬁnal positions (HH stage 14, Fig. 2E). At later
stages, GFP was expressed throughout the head mesenchyme.
The ECR1 region also mediated GFP expression in the neural crest
cells at the hindbrain level, including the rhombomere (r) 4 and r6
streams and the branchial arches, the latter corresponding to the
migrating vagal crest stream. However, no GFP expression was
seen in the trunk neural crest, even though a co-electroporated
construct expressing RFP ubiquitously showed expression
throughout the embryo (data not shown). These results show that
ECR1 enhancer mediates expression in the cranial neural crest
similar to that of endogenous Ets-1.
In addition to neural crest, expression of GFP was detected in
the otic placode (Fig. 2C), otic pit (Fig. 2D) and otic vesicle (Fig. 2E).
In situ hybridization of embryos electroporated with ECR1 showed
that the endogenous Ets-1 expression overlapped with that of GFP
expression driven by the ECR1 enhancer in HH stage 10 (Fig. 2F
and G) and HH stage 11 embryos (Fig. 2H and I). The ECR1 driven
GFP expression also reproduced endogenous Ets-1 expression in
the otic placode (Fig. 2H and I). However, it did not drive
expression of GFP in the head mesoderm or endothelial cells
despite the fact that these regions also express Ets-1. Thus the
ECR1 enhancer recapitulates endogenous Ets-1 expression speci-
ﬁcally in the neural crest and otic placode.
A conserved 288 bp element is the minimal essential core regulatory
element of enhancer ECR1
To narrow down the region necessary for enhancer activity, we
progressively deleted the ends of the ECR1 enhancer to deﬁne the
minimal required sequence to mediate reporter activity. A 288 bp
fragment retained the GFP expression pattern of the full length
ECR1 enhancer construct, albeit at a somewhat reduced level
compared to the ECR1 Cherry construct. Enhancer activity
was eliminated when the conserved sequence at either end
was removed, indicating that the minimum enhancer region was
288 bp (Fig. 3A).
As a ﬁrst step in identifying potential inputs that mediate Ets-1
expression in the neural crest, we explored potential transcription
factor binding sites within the minimal ECR1 enhancer using the
JASPAR database (Bryne et al., 2008) (Fig. 3B). This analysis
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Fig. 1. Ets-1 is expressed in the dorsal neural tube of HH stage 8 embryos (A) and in the migrating crest of HH stage 10 (B) HH stage 12 (C) and HH stage 14 (D) chicken
embryos. Arrows point to the Ets-1 expression in the otic pit.
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Fig. 2. A. Using the UCSC genome browser, we identiﬁed conserved regions near the Ets-1 gene. Conserved regions were cloned into pTK vector and tested by
electroporation for neural crest enhancer activity (A). One of these, ECR1 (red arrow) had enhancer activity. ECR1 drives GFP expression in the neural crest of HH stage 9 (B,B
′), HH stage 10 (C,C′), HH stage 12 (D,D′) and HH stage 14 (E,E′) embryos. The rectangles in B, C, D, and E correspond to higher magniﬁcation images of the midbrain (B′), otic
placode (C′), otic pit (D′) and otic vesicle (E′) respectively. Expression of GFP by ECR1 in HH stage 9 embryos (F) recapitulates the Ets-1 expression as seen by in situ
hybridization (G). Similarly, expression of GFP by ECR1 in HH stage 11 embryos (H) recapitulates the Ets-1 expression as seen by in situ hybridization (I).
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revealed consensus binding sequences for SoxE genes, TFAP2A, Ets
genes, cMyc/E-box sequence, a homeobox binding site, and a Fox
transcription factor binding site. Interestingly, members of each of
these transcription factor families have been identiﬁed as func-
tioning within the neural crest GRN.
Dissection of ECR1 reveals eight critical binding sites for enhancer
activity
To test the functional relevance of these putative binding
motifs, we turned to mutational analysis. Constructs were created
with mutations of each of the putative binding motifs to deter-
mine if these conserved sites are required for ECR1 enhancer
activity. To this end, the endogenous consensus sequences were
replaced with heterologous sequence from GFP. Mutant constructs
were then co-electroprated along with a ECR1-pTK-Cherry control
constructs to determine the differences between the GFP expres-
sion driven by the mutant ECR1 enhancer compared with Cherry
ﬂuorescent protein expression driven by the wild type ECR1
enhancer construct.
Seven SoxE sequences were tested in this way. Of these,
mutation of three sites (SoxEa shown in Fig. 4A and B; SoxEb
and SoxEc are not shown) resulted in signiﬁcant reduction of the
ﬂuorescence signal compared to the intact ECR1 control, suggest-
ing that they were important for mediating enhancer activity in
the cranial neural crest. Similarly replacement of the homeobox
consensus sequence eliminated enhancer activity (Fig. 4C and D).
Mutation of the Ets (Fig. 4E and F) or TFAP2 (Fig. 4G and H)
consensus sequences decreased enhancer activity, albeit less than
removal of either Hox or Sox sites. Mutation of the Fox sequence
also reduced activity in the neural crest compared to the wild
type enhancer. However, reporter activity in the otic pit was
unchanged, suggesting differential regulation in the neural crest
and ear (Fig. 4I and J)
In contrast to the above mutations all of which reduced
enhancer-mediated reporter activity, mutation of cMyc/E-box
consensus sequence resulted in a very different change in reporter
expression (the E-box consensus sequence is part of the longer
cMyc consensus sequence). While no detectable differences were
noted in reporter expression in the cranial neural crest compared
with the wild type enhancer, reporter expression was expanded in
the hindbrain region (Fig. 4K and L). These results suggest that the
Myc/E-box site is bound by a repressor of Ets-1 activity at
hindbrain levels. However, we never detected enhancer activity
in the trunk neural crest either with the Myc/E-box mutant or with
any other mutant we tested.
Knockdown of potential regulators reveals transcriptional inputs into
ECR1
By identifying the sequences in the ECR1 enhancer that are
required for enhancer activity, we identiﬁed several transcription
factor families that that may be involved in mediating Ets-1
expression in the cranial neural crest. To determine which tran-
scription factors are necessary for enhancer activity, we took a
candidate approach to determine speciﬁc factors that are required
for reporter activity by co-electroporating antisense morpholino
oligos (MO) against speciﬁc factors together with the wild type
ECR1 reporter construct.
As potential transcriptional inputs into the homeobox consen-
sus sequences, we tested the effects of knock-down of Msx1, Msx2
and Pax7, all of which are neural plate border speciﬁer genes
(Meulemans and Bronner-Fraser, 2004). The results show that
a combination of Msx1 and Msx2 MO signiﬁcantly abrogated
Fig. 3. Conservation of ECR1 using UCSC gene browser (A). The conserved regions are required for ECR1 enhancer activity. The minimal enhancer is depicted as a solid lie at
the bottom. There are a number of transcription factor binding consensus sites conserved in the ECR1 region (B) as determined using the JASPAR database. The open
rectangles correspond to SoxE consensus sequences whose mutation did alter enhancer activity.
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enhancer mediated reporter activity in the neural crest compared
to the control MO (Fig. 5C and D). Similarly, electroporation of
Pax7 MO resulted in a reduction in enhancer activity compared to
the control MO side (Fig. 5E and F). These results suggest that a
combination of neural plate border genes is important for activa-
tion of Ets-1 expression in the neural crest.
Fig. 4. Putative transcription binding sites were mutated using fusionPCR and cloned into pTK vector. The constructs were co-electroporatedwith a pTK-ECR1 construct
expressing Cherry. Mutations in the SoxE sites (B) reduced enhancer activity versus intact ECR1 driving Cherry expression (A). Mutations in the core Hox2 sequence (D) also
reduced enhancer activity compared to control (C ). Mutations in the consensus Ets-1 sequence (F) decrease enhancer activity compared to controls (E). Similarly, the control
Cherry construct (G) had higher enhancer activity compared to the TFAP2 consensus site mutation construct (H). Mutations in a Fox consensus sequence reduced neural crest
GFP expression but not otic expression (I), compared to control (J). Mutations in a putative cMyc/E-box binding sequence increased enhancer activity in the vagal neural crest
only (K) compared to controls (L).
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Three SoxE sites appeared to be essential for ECR1 activity.
Sox9, a member of the SoxE gene family of transcription factors, is
known to be important for neural crest development (Cheung and
Briscoe, 2003; Mori-Akiyama et al., 2003). By electroporating a
Sox9 MO on the right side and a control MO on the left side of the
same embryo, we noted that Sox9 MO caused a reduction of ECR1
enhancer activity (Fig. 5A and B). In contrast, MO to its paralog,
Sox10, had little effect on its own and did not enhance the knock-
down when co-electroporated with Sox9 MO (data not shown).
This suggests that Sox9, but not Sox10, is required for enhancer
activity. This is interesting since both Sox9 and Ets-1 are direct
inputs into Sox10 (Betancur et al., 2010B). To test if Sox9 was
sufﬁcient to activate the ECR1 enhancer, we over-expressed Sox9
plus the enhancer and found that it was able to ectopically induce
its activity (Supplementary Fig. 1A–D).
Finally, we tested putative inputs into the Fox, Ets, TFAP2, and
cMyc/E-Box sites. One Fox family member well-known to be
expressed in the neural crest is FoxD3. FoxD3 expression in the
neural folds slightly precedes that of Ets-1 (Théveneau et al.,
2007)). To test whether FoxD3 is a required input into ECR1
activity, we electroporated a translation-blocking FoxD3 MO
together with ECR1 enhancer constructs. The results show that
the FoxD3 MO reduces ECR1 enhancer activity in the neural crest
compared to the control MO side (Fig. 5G and H). However, there
was no change in reporter expression in the ear, suggesting
differential regulation of the same enhancer in these two tissues.
Fig. 5. Morpholino oligos (MO) to transcription factors (right side) and control (left side) were co-electroporated with ECR1-pTK Cherry. MO to Sox9 (A) reduced ECR1
enhancer activity (B). A combination of Msx1 and Msx2 MO (C) reduced enhancer activity in the neural crest (D) compared to the control MO. The Pax7 MO electroplated side
(E) had reduced enhancer activity compared to the control MO side (F). FoxD3 MO (G) also reduced the ECR1 enhancer activity compared to the control MO (H). Similarly, the
Ets-1 MO (I) reduced enhancer activity versus the control MO (J). The MO to TFAP2A (K) reduced enhancer activity compared to the control MO side (L).
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Curiously, FoxD3 has been shown to be a repressor in neural crest
(Simões-Costa et al., 2012). Thus the effects with the FoxD3 MO
may be indirect. Also we cannot exclude the possibility that some
other Fox family member, not yet identiﬁed, may be responsible
for activation of this site. Alternatively, FoxD3 may act as an
activator in this case, though we are unaware of any evidence
that FoxD3 can act in this way.
Additional ECR1 inputs observed in this study include Ets-1
itself and TFAP2A. Our results reveal that a translation blocking
Ets-1 MO reduced ECR1 enhancer activity compared to the control
MO side (Fig. 5I and J). This suggests that Ets-1 autoregulates its
own expression. In addition, a TFAP2A MO resulted in a reduction
in enhancer activity in the neural crest compared to a control MO
(Fig. 5K and L). In contrast, we saw no effect using either a cMyc
MO or a Snail2 MO (data not shown).
To test speciﬁcity of the morpholino, we co-electroporated
embryos with TFAP2-MO together with the mutated ECR1 con-
struct lacking the TFAP2 binding site. The results show no effect on
change in the small amount of residual Cherry expression (Sup-
plementary Fig. 2A and B). Similarly, Ets-1 morpholino did not
alter reporter expression of the construct in which the Ets binding
site was mutated, nor were there changes in immunostaining
(Supplementary Fig. 2D and C). Interesting, individual TFAP2 or
Ets-1 morpholinos did not alter endogenous Ets-1 mRNA expres-
sion (Supplementary Fig. 3A and B), nor did MO to FoxD3, cMyc, or
Sox9 (Supplementary Fig. 3C–E).
Taken together, these results show that numerous inputs are
required for mediating enhancer activity in the neural crest. Notably,
Sox9, Msx1, Msx2, FoxD3, Ets-1 and TFAP2A all are required for
activation of Ets-1 expression in the cranial neural crest.
Discussion
Recent studies have formulated a gene regulatory network
(GRN) that explains many aspects of cranial neural crest develop-
ment (Meulemans and Bronner-Fraser, 2004; Sauka-Spengler and
Bronner-Fraser, 2008; Betancur et al. 2010A). Neural crest cells are
ﬁrst induced in a swathe of epiblast between the neural and non-
neural ectoderm at the gastrula stage. This induction is mediated
by the combined action of signaling molecules including BMPs,
FGFs ad WNTs (Stuhlmiller and Garcia-Castro, 2012). These signals
activate a set of genes, referred to as neural border speciﬁer
genes that maintain the cells in a state competent to form neural
crest. Transcription factors expressed in the neural borders,
including Msx1, Id, cMyc, AP2a, Zic1 as well as Pax7, then act to
induce the expression of the neural crest speciﬁer genes, including
Snail2, Sox9, Sox10, FoxD3, cMyb and Ets-1, that imbue cranial
neural crest cells with the ability to undergo an epithelial-to-
mesenchymal transition, to migrate extensively and ultimately
differentiate into multiple derivatives.
The Ets-1 transcription factor is an important input into the
neural crest GRN at cranial levels. Recent work has shown that Ets-
1 directly regulates cranial neural crest enhancers that mediate
expression of Sox10 and the FoxD3 (Betancur et al. 2010B; Simões-
Costa et al., 2012). To understand regulation of Ets-1 itself, we have
identiﬁed an Ets-1 minimal enhancer, ECR1, that mediates reporter
expression in the cranial neural crest and otic placode and
examined the inputs required for this expression. The ECR1
enhancer closely recapitulates the endogenous pattern of Ets-1
expression in the neural crest. We detect GFP activity in the
premigratory neural crest as early as 6 somite stage. GFP expres-
sion remains evident on the neural crest continuously throughout
the migratory phase as well as later, when the neural crest have
reached their destination in the head and the branchial arches at
HH stage 14, the last stage examined.
In addition to its expression in the neural crest, Ets-1 is well
known for its expression in the endothelial, immune and hema-
topoetic systems (Dittmer, 2003). Previously, an Ets-1 regulatory
region that controls expression in erythropoetic cells has been
identiﬁed. Its inputs include Pea3, AP1, TFAP2A, Oct, and Ets-1
itself (Jorcyk et al., 1991; Oka et al., 1991; Chen and Wright, 1993).
In mice, the ﬁrst intron was shown to be necessary for expression
in endothelial cells as well as erythropoetic cells. Although a 5′
ﬂanking region was reported to drive expression in the branchial
arches, it was not examined further (Jorcyk et al., 1997).
In contrast to cranial neural crest and otic expression, we did
not observe reporter expression mediated by ECR1 or other
conserved regions in other cell types that express Ets-1, like
endothelial cells or the head mesoderm. There are several possible
explanations for this. Perhaps the endothelial enhancer is not
conserved between chicken and mammals, or its conservation was
below the level of detection using the UCSD genome browser. Also,
the enhancers controlling endothelial and head mesoderm Ets-1
expression may be located outside the regions we examined.
Another possibility is that there may be multiple enhancers whose
coordinate activation is required to recapitulate expression in
these other cell types. The results from the mouse transgenic
studies support the latter possibility (Jorcyk et al., 1997).
We tested a number of conserved putative consensus tran-
scription factor binding sites within the ECR1 enhancer. A con-
served homeobox consensus recognition sequence is required for
cranial neural crest enhancer activity and represents a potential
binding site for several neural plate border speciﬁer genes,
including Pax7, Msx1 and Msx2 (Meulemans and Bronner-Fraser,
2004). Consistent with this possibility, our results show that
knock-down of Pax7, or Msx1/2 reduces reporter activity suggest-
ing that both of these factors are required for expression mediated
by the ECR1 enhancer. A Fox gene consensus binding sequence
overlaps with the homeobox consensus sequence that is important
for ECR1 enhancer activity and morpholino knockdown shows that
FoxD3 appears to mediate expression through this binding site.
Of the seven conserved SoxE transcription factor consensus
binding sites within ECR1, three were individually necessary for
proper reporter activity. We were unable to discern any differences
between the active site sequences and the inactive site sequences.
Sox9 is the most likely input into the SoxE binding sites in the
ECR1 enhancer. Not only is it expressed early during neural crest
development, but it also has been shown to be important for
regulation of Sox10 enhancer activity in the cranial neural crest
(Betancur et al., 2010B) and its expression precedes that of Sox10
and Ets-1. Because Ets-1 is expressed prior to onset of Sox10
transcription, the lack of obvious effect of knocking down Sox10 on
Ets-1 enhancer activity is not unexpected. TFAP2A is also required
for ECR1 enhancer activity as well as for the activity of an
additional Sox10 enhancer discovered in the mouse (Werner
et al., 2007; Wahlbuhl et al., 2012).
Interestingly, our results show that mutation of a conserved
cMyc/E-box consensus sequence actually increases enhancer activity
in the hindbrain neural crest. Thus, this is site is likely to represent a
repressor binding site. In contrast, we failed to detect any conserved
neural crest recognition sites involved in trunk neural crest devel-
opment. A possible explanation for the lack trunk expression is the
rostrally limited expression of one or more of the upstream factors.
Alternatively, there may be other yet to be identiﬁed sites necessary
for neural crest enhancer activity or which may contain repressors of
trunk neural crest expression. It is not surprising that expression of a
particular gene would be mediated by a combination of activation
and repression, with the latter limiting or reducing the level of gene
expression in particular locations and times.
These data show that many of the same transcription factors
that directly regulate other neural crest speciﬁers (e.g. Sox9, Pax7,
M. Barembaum, M.E. Bronner / Developmental Biology 382 (2013) 567–575574
FoxD3) also regulate Ets-1, which in turn regulates other neural
crest speciﬁers such as Sox10 and FoxD3. Thus the neural crest
speciﬁer genes in the neural crest GRN appear not only to receive
an initial signal (such as from Pax7, Msx1, Msx2, and Sox9), but
also act to reinforce that signal, both by acting on other speciﬁers
(FoxD3 and Sox10) and by feeding back upon themselves.
A summary of known direct and proposed inputs into the neural
crest gene regulatory network inﬂuencing expression of Ets-1 and
other neural crest speciﬁer genes is shown in Fig. 6. As illustrated,
there is abundant feedback that could act to amplify the initial
signal, ensuring that the neural crest cells remain speciﬁed by this
reinforcement.
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